kabutan

MEDINET Co., Ltd.(2370) Summary

2370
TSE Growth
MEDINET Co., Ltd.
29
JPY
-1
(-3.33%)
Dec 12, 3:30 pm JST
0.18
USD
Dec 12, 1:30 am EST
Result
PTS
outside of trading hours
29.8
Dec 13, 12:06 am JST
Summary Chart Historical News Financial Result
PER
PBR
2.03
Yield
ー%
Margin Trading Ratio
Stock Price
Dec 12, 2025
Opening Dec 12, 9:00 am
29 JPY 0.18 USD
Previous Close Dec 11
30 JPY 0.19 USD
High Dec 12, 9:01 am
30 JPY 0.19 USD
Low Dec 12, 9:00 am
29 JPY 0.18 USD
Volume
826,700
Trading Value
0.02B JPY 0.16M USD
VWAP
29.51 JPY 0.19 USD
Minimum Trading Value
2,900 JPY 18 USD
Market Cap
7.68B JPY 0.05B USD
Number of Trades
99
Liquidity & Number of Trades
As of Dec 12, 2025
Liquidity
Mid
1-Year Average
159
1-Year High Jun 24, 2025
1,875
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 5, 2025 0 12,503,000
Nov 28, 2025 0 12,298,000
Nov 21, 2025 0 12,171,500
Nov 14, 2025 0 12,804,700
Nov 7, 2025 0 13,920,100
Company Profile
MEDINET Co., Ltd. is a venture business originating from the Institute of Medical Science at the University of Tokyo. The company provides comprehensive services for cancer immunotherapy and is also involved in pharmaceutical development.
Sector
Services
MEDINET Co., Ltd. operates in the cell processing industry and regenerative medicine product business. In the cell processing industry, the company manufactures specific cell products for medical institutions, contracts the production of clinical and trial cell products for companies and universities, manages cell culture processing facilities, and provides dispatch and education systems for cell processing technicians. In the regenerative medicine product business, MEDINET Co., Ltd. aims to obtain manufacturing and marketing approval for regenerative medicine products through joint research with universities and other institutions.